GlassScriptPhysician profile
Michael Scott Anglin
NPI 1922189554
$801.52
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was more than what 82% of Pediatric Dentistry providers received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $40.62 · 2022: $99.52 · 2023: $220 · 2024: $17.76 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $329.57 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $156.33 | 2019 | |
| Henry Schein, INC. | $99.52 | 2022 | |
| Biolase, INC. | $88.68 | 2019 | |
| Solventum Corporation | $47.13 | 2024-2025 | Clarity Aligners, Clinpro 5000, Filtek |
| Biohorizons Implant Systems INC. | $28.02 | 2020 | |
| Envista Holdings Corporation | $17.53 | 2025 | Sonicfill |
| Dentsply Sirona INC | $12.60 | 2020 | |
| Elevate Oral Care | $12.27 | 2019 | |
| Voco America INC. | $9.87 | 2025 | Futurabond U, Grandioso Light Flow, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Anglin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.